OnabotulinumtoxinA for Systemic Sclerosis-associated Raynaud's Phenomenon: A Multi-Institutional Study on Accessibility and Effectiveness

被引：1
|
作者：
Kassamali, Bina [1 ,2 ]
Desai, Sheena [1 ,3 ]
Min, Michelle S. [1 ,2 ]
Mazori, Daniel R. [1 ,2 ]
Villa-Ruiz, Camila [1 ,4 ]
Kus, Kylee J. B. [1 ,5 ]
Cobos, Gabriela A. [1 ,2 ]
Merola, Joseph [1 ,2 ,6 ]
LaChance, Avery [1 ,2 ]
Vleugels, Ruth Ann [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Tufts Univ, Sch Med, Boston, MA USA
[4] Ponce Hlth Sci Univ, Sch Med, Ponce, Peoples R China
[5] Oakland Univ, William Beaumont Sch Med, Rochester, MI USA
[6] Brigham & Womens Hosp, Div Rheumatol, Dept Med Immunol & Allergy, Boston, MA USA
来源：
JOURNAL OF DRUGS IN DERMATOLOGY | 2021年 / 20卷 / 11期
关键词：
BOTULINUM-TOXIN;
D O I：
10.36849/JDD.6135
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1257 / 1259
页数：3
相关论文
共 50 条
  • [41] Efficacy of cilostazol for the treatment of Raynaud’s phenomenon in systemic sclerosis patients
    Simone Negrini
    Francesca Spanò
    Elena Penza
    Daniela Rollando
    Francesco Indiveri
    Gilberto Filaci
    Francesco Puppo
    Clinical and Experimental Medicine, 2016, 16 : 407 - 412
  • [42] The clinical relevance of Raynaud’s phenomenon symptom characteristics in systemic sclerosis
    Michael Hughes
    Suiyuan Huang
    John D Pauling
    Maya Sabbagh
    Dinesh Khanna
    Clinical Rheumatology, 2022, 41 : 3049 - 3054
  • [43] Sarpogrelate hydrochloride therapy for Raynaud'S phenomenon in patients with systemic sclerosis
    Ogawa, Takehiko
    Ogura, Takehisa
    Izumi, Yuichi
    Hirata, Ayako
    Hayashi, Norihide
    Miura, Reiko
    Morita, Shinobu
    Kujime, Rie
    Ogawa, Kana
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S821 - S822
  • [44] Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis
    Hettema, M. E.
    Zhang, D.
    Bootsma, H.
    Kallenberg, C. G. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) : 1398 - 1399
  • [45] Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis:: a comparative study
    Pamuk, Gulsum Emel
    Turgut, Burhan
    Pamuk, Omer Nuri
    Vural, Ozden
    Demir, Muzaffer
    Cakir, Necati
    BLOOD COAGULATION & FIBRINOLYSIS, 2007, 18 (04) : 297 - 302
  • [46] Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis
    Rajkumar, VS
    Sundberg, C
    Abraham, DJ
    Rubin, K
    Black, CM
    ARTHRITIS AND RHEUMATISM, 1999, 42 (05): : 930 - 941
  • [47] Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon
    Porciello, G
    Scarpato, R
    Ferri, C
    Storino, F
    Cagetti, F
    Morozzi, G
    Bellisai, F
    Migliore, L
    Marcolongo, R
    Galeazzi, M
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (06) : 1244 - 1247
  • [48] Lymphocyte-endothelium interaction in systemic sclerosis and Raynaud's phenomenon
    Della Bella, S
    Molteni, M
    Mocellin, C
    Fumagalli, S
    Bonara, P
    Scorza, R
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (06) : 647 - 654
  • [49] Management of Raynaud's phenomenon in systemic sclerosis-a practical approach
    Fernandez-Codina, Andreu
    Canas-Ruano, Esperanza
    Pope, Janet E.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2019, 4 (02) : 102 - 110
  • [50] EPIDEMIOLOGICAL STUDY FOR THE EARLY DETECTION OF SYSTEMIC SCLEROSIS IN PATIENTS WITH RAYNAUD PHENOMENON
    Beltran-Catalan, E.
    Roman-Ivorra, J. A.
    Feced, C.
    Alegre, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S75 - S75
12345